Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.8.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.8.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EU.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EU.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EJ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BM.1.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BM.1.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.1.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.123.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.123.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.123.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.9.2.2 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.9.2.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.9.2.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EW.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EW.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EW.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBPNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used